Alaunos Therapeutics Ownership 2024 | Who Owns Alaunos Therapeutics Now?
Institutional Ownership
0.00%
Insider Ownership
14.30%
Retail Ownership
85.70%
Institutional Holders
1.00
Alaunos Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -40 | -100.00% | - | Jun 30, 2024 |
Alaunos Therapeutics's largest institutional shareholder is EVERSOURCE WEALTH ADVISORS, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -40 | -100.00% | - | Jun 30, 2024 |
The largest Alaunos Therapeutics shareholder by % of total assets is EVERSOURCE WEALTH ADVISORS, LLC. The company owns 0.00 shares of Alaunos Therapeutics (TCRT), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -40 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Alaunos Therapeutics's largest institutional buyer is EVERSOURCE WEALTH ADVISORS, LLC. The company purchased -40.00 stocks of TCRT, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -40 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Alaunos Therapeutics's biggest institutional seller is EVERSOURCE WEALTH ADVISORS, LLC. The company sold -40.00 shares of TCRT, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -40 | -100.00% | - | Jun 30, 2024 |
Alaunos Therapeutics's largest sold out institutional shareholder by shares sold is EVERSOURCE WEALTH ADVISORS, LLC, sold -40.00 shares, valued at -, as of undefined.
Alaunos Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Federated Hermes MDT Series | 0.09% | 232,300 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.09% | 131,413 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.09% | 1,105,848 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.05% | 326,456 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.05% | 30,832 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.03% | 254,901 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.03% | 373,005 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.03% | 6,592 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.03% | 151,500 | 43,820 | 40.69% | Mar 31, 2020 |
| Trust for Advised Portfolios | 0.03% | 524,242 | - | - | Dec 31, 2023 |
| FORUM FUNDS II | 0.02% | 23,700 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.02% | 463 | - | - | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 77,560 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 22,688 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.01% | 18,832 | - | - | Mar 31, 2024 |
| Capitol Series Trust | 0.01% | 61,300 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 107,060 | - | - | Jan 31, 2024 |
| AMG FUNDS III | 0.00% | 17,474 | - | - | Mar 28, 2024 |
| SunAmerica Specialty Series | 0.00% | 1,758 | - | - | Apr 30, 2021 |
| VANGUARD WORLD FUND | 0.00% | 688,847 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 6,843 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 78,095 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 24,426 | - | - | Mar 31, 2024 |
| Virtus Strategy Trust | 0.00% | 39,208 | - | - | Mar 28, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 1,500 | - | - | Dec 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 959,610 | - | - | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 237,089 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 608,648 | 608,648 | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 59,664 | - | - | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 89,919 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 945,990 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 10,493 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 19,981 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 116,349 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 44,356 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 137,047 | 137,047 | - | Feb 29, 2024 |
| LoCorr Investment Trust | 0.00% | 15,847 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 2,433 | - | - | Mar 28, 2024 |
| EQ ADVISORS TRUST | 0.00% | 693,862 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 2,000 | - | - | Dec 31, 2023 |
| Victory Portfolios II | 0.00% | 24,195 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 4,483 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 1,405,631 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 706,160 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,834 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 1,106 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 77,695 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 791,393 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 18,988 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 7,309 | 7,309 | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 15,296 | - | - | Feb 29, 2024 |
| Virtus Investment Trust | 0.00% | 7,090 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 27,959 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 1,249 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 5,927 | - | - | Mar 28, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 202 | - | - | Dec 31, 2023 |
| SPDR INDEX SHARES FUNDS | 0.00% | 31,752 | - | - | Mar 31, 2024 |
| Pacer Funds Trust | 0.00% | 6,480 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 620 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 111,494 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 9,102 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 179,917 | - | - | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 22,245 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 647 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 5,824 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 1,392 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 2,059 | - | - | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 2,409,626 | - | - | Mar 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 3,344 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 10,305 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 77,035 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 17,475 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 12,101 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 33,327 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 32,595 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 25,913 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 600 | - | - | Feb 29, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 33,767 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 22,349 | - | - | Mar 28, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 64,346 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 956 | - | - | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 25,658 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 181 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 2,828 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 267 | 267 | - | Mar 31, 2024 |
Alaunos Therapeutics's largest mutual fund holder by % of total assets is "Federated Hermes MDT Series", owning 232.30K shares, compromising 0.09% of its total assets.
Alaunos Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 1 | -98.80% |
| 31 Dec, 23 | 83 | -9.78% |
| 30 Sep, 23 | 92 | -14.02% |
| 30 Jun, 23 | 107 | -7.76% |
| 31 Mar, 23 | 116 | -10.77% |
| 31 Dec, 22 | 130 | -1.52% |
| 30 Sep, 22 | 132 | 4.76% |
| 30 Jun, 22 | 126 | -14.86% |
| 31 Mar, 22 | 148 | -13.45% |
| 31 Dec, 21 | 171 | -0.58% |
| 30 Sep, 21 | 172 | 5.52% |
| 30 Jun, 21 | 163 | 2.52% |
| 31 Mar, 21 | 159 | -3.05% |
| 31 Dec, 20 | 164 | 1.23% |
| 30 Sep, 20 | 162 | 3.85% |
| 30 Jun, 20 | 156 | 1.96% |
| 31 Mar, 20 | 153 | -4.38% |
| 31 Dec, 19 | 160 | 3.90% |
| 30 Sep, 19 | 154 | 2.67% |
| 30 Jun, 19 | 150 | 12.78% |
| 31 Mar, 19 | 133 | -6.99% |
| 31 Dec, 18 | 143 | - |
| 30 Sep, 18 | 143 | -2.05% |
| 30 Jun, 18 | 146 | 0.69% |
| 31 Mar, 18 | 145 | 2.84% |
| 31 Dec, 17 | 141 | 0.71% |
| 30 Sep, 17 | 140 | 2.19% |
| 30 Jun, 17 | 137 | -4.20% |
| 31 Mar, 17 | 143 | -12.27% |
| 31 Dec, 16 | 163 | 1.24% |
| 30 Sep, 16 | 161 | -9.55% |
| 30 Jun, 16 | 178 | 8.54% |
| 31 Mar, 16 | 164 | -6.82% |
| 31 Dec, 15 | 176 | 11.39% |
| 30 Sep, 15 | 158 | -14.13% |
| 30 Jun, 15 | 184 | 22.67% |
| 31 Mar, 15 | 150 | 57.89% |
| 31 Dec, 14 | 95 | -8.65% |
| 30 Sep, 14 | 104 | 1.96% |
| 30 Jun, 14 | 102 | -2.86% |
| 31 Mar, 14 | 105 | 22.09% |
| 31 Dec, 13 | 86 | 1.18% |
| 30 Sep, 13 | 85 | 8.97% |
| 30 Jun, 13 | 78 | 85.71% |
| 31 Mar, 13 | 42 | 23.53% |
| 31 Dec, 12 | 34 | 3.03% |
| 30 Sep, 12 | 33 | 6.45% |
| 30 Jun, 12 | 31 | 14.81% |
| 31 Mar, 12 | 27 | 12.50% |
| 31 Dec, 11 | 24 | 26.32% |
| 30 Sep, 11 | 19 | -34.48% |
| 30 Jun, 11 | 29 | 7.41% |
| 31 Mar, 11 | 27 | 17.39% |
| 31 Dec, 10 | 23 | 15.00% |
| 30 Sep, 10 | 20 | -9.09% |
| 30 Jun, 10 | 22 | 144.44% |
| 31 Mar, 10 | 9 | 12.50% |
| 31 Dec, 09 | 8 | 100.00% |
| 30 Sep, 09 | 4 | -33.33% |
| 30 Jun, 09 | 6 | 20.00% |
| 31 Mar, 09 | 5 | -16.67% |
| 31 Dec, 08 | 6 | - |
| 30 Sep, 08 | 6 | 20.00% |
| 30 Jun, 08 | 5 | 25.00% |
| 31 Mar, 08 | 4 | -42.86% |
| 31 Dec, 07 | 7 | 40.00% |
| 30 Sep, 07 | 5 | -16.67% |
| 30 Jun, 07 | 6 | - |
| 31 Mar, 07 | 6 | 50.00% |
| 31 Dec, 06 | 4 | - |
| 30 Jun, 06 | 1 | - |
As of 31 Mar 24, 1 institutions are holding Alaunos Therapeutics's shares, representing a decrease of -98.80% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 40 | -100.00% |
| 31 Dec, 23 | 41,174,501 | -26.49% |
| 30 Sep, 23 | 56,012,255 | -16.44% |
| 30 Jun, 23 | 67,033,956 | -5.32% |
| 31 Mar, 23 | 70,801,563 | -9.01% |
| 31 Dec, 22 | 77,812,599 | 4.33% |
| 30 Sep, 22 | 74,585,144 | 1.99% |
| 30 Jun, 22 | 73,126,482 | -27.10% |
| 31 Mar, 22 | 100,314,073 | -29.80% |
| 31 Dec, 21 | 142,905,382 | 34.36% |
| 30 Sep, 21 | 106,357,480 | -5.50% |
| 30 Jun, 21 | 112,545,246 | -4.12% |
| 31 Mar, 21 | 117,383,729 | 5.22% |
| 31 Dec, 20 | 111,554,996 | 3.80% |
| 30 Sep, 20 | 107,467,415 | 4.57% |
| 30 Jun, 20 | 102,769,692 | 3.99% |
| 31 Mar, 20 | 98,826,017 | 15.22% |
| 31 Dec, 19 | 85,770,320 | 3.76% |
| 30 Sep, 19 | 82,666,131 | 17.80% |
| 30 Jun, 19 | 70,175,585 | 12.38% |
| 31 Mar, 19 | 62,447,382 | 1.34% |
| 31 Dec, 18 | 61,621,466 | 7.21% |
| 30 Sep, 18 | 57,478,663 | 1.66% |
| 30 Jun, 18 | 56,537,882 | -2.50% |
| 31 Mar, 18 | 57,990,213 | 1.38% |
| 31 Dec, 17 | 57,198,716 | -1.28% |
| 30 Sep, 17 | 57,938,065 | -4.13% |
| 30 Jun, 17 | 60,433,369 | 13.52% |
| 31 Mar, 17 | 53,235,763 | -1.53% |
| 31 Dec, 16 | 54,062,432 | -1.38% |
| 30 Sep, 16 | 54,818,463 | -8.61% |
| 30 Jun, 16 | 59,985,931 | 7.07% |
| 31 Mar, 16 | 56,024,521 | -8.11% |
| 31 Dec, 15 | 60,969,223 | -3.68% |
| 30 Sep, 15 | 63,300,262 | -4.06% |
| 30 Jun, 15 | 65,976,582 | -3.69% |
| 31 Mar, 15 | 68,501,010 | 49.17% |
| 31 Dec, 14 | 45,922,525 | -4.43% |
| 30 Sep, 14 | 48,049,607 | -5.47% |
| 30 Jun, 14 | 50,831,715 | -9.44% |
| 31 Mar, 14 | 56,130,056 | 2.64% |
| 31 Dec, 13 | 54,688,537 | 34.81% |
| 30 Sep, 13 | 40,567,489 | 2.33% |
| 30 Jun, 13 | 39,643,429 | 40.61% |
| 31 Mar, 13 | 28,193,221 | -5.69% |
| 31 Dec, 12 | 29,893,241 | 6.16% |
| 30 Sep, 12 | 28,158,200 | 1.26% |
| 30 Jun, 12 | 27,808,953 | 65.40% |
| 31 Mar, 12 | 16,813,551 | -20.47% |
| 31 Dec, 11 | 21,139,899 | 98.37% |
| 30 Sep, 11 | 10,656,705 | -27.13% |
| 30 Jun, 11 | 14,624,783 | 141.79% |
| 31 Mar, 11 | 6,048,479 | -13.84% |
| 31 Dec, 10 | 7,019,856 | -12.06% |
| 30 Sep, 10 | 7,982,382 | -3.34% |
| 30 Jun, 10 | 8,258,136 | 59.67% |
| 31 Mar, 10 | 5,171,873 | -25.94% |
| 31 Dec, 09 | 6,982,909 | 974.46% |
| 30 Sep, 09 | 649,898 | -33.45% |
| 30 Jun, 09 | 976,532 | 27.78% |
| 31 Mar, 09 | 764,231 | -6.20% |
| 31 Dec, 08 | 814,760 | 84.03% |
| 30 Sep, 08 | 442,729 | -77.23% |
| 30 Jun, 08 | 1,944,624 | 86.09% |
| 31 Mar, 08 | 1,045,001 | -53.56% |
| 31 Dec, 07 | 2,250,304 | 3.64% |
| 30 Sep, 07 | 2,171,320 | 89.79% |
| 30 Jun, 07 | 1,144,038 | -7.31% |
| 31 Mar, 07 | 1,234,308 | -39.72% |
| 31 Dec, 06 | 2,047,627 | - |
| 30 Jun, 06 | 647,948 | - |
Alaunos Therapeutics (TCRT) has 40.00 shares outstanding as of 31 Mar 24, down -100.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 0.00% | - |
| 31 Dec, 23 | 17.15% | 3.14% |
| 30 Sep, 23 | 23.36% | 2.99% |
| 30 Jun, 23 | 27.97% | 3.21% |
| 31 Mar, 23 | 29.54% | 2.30% |
| 31 Dec, 22 | 35.84% | 2.98% |
| 30 Sep, 22 | 34.67% | 3.00% |
| 30 Jun, 22 | 34.01% | 1.56% |
| 31 Mar, 22 | 46.67% | 1.05% |
| 31 Dec, 21 | 66.57% | 2.71% |
| 30 Sep, 21 | 49.57% | 1.80% |
| 30 Jun, 21 | 52.49% | 1.74% |
| 31 Mar, 21 | 54.86% | 1.94% |
| 31 Dec, 20 | 53.21% | 2.09% |
| 30 Sep, 20 | 50.49% | 2.16% |
| 30 Jun, 20 | 48.30% | 1.97% |
| 31 Mar, 20 | 49.46% | 1.90% |
| 31 Dec, 19 | 51.07% | 2.18% |
| 30 Sep, 19 | 48.45% | 2.54% |
| 30 Jun, 19 | 43.64% | 2.89% |
| 31 Mar, 19 | 38.87% | 2.11% |
| 31 Dec, 18 | 42.94% | 2.59% |
| 30 Sep, 18 | 40.71% | 2.53% |
| 30 Jun, 18 | 40.09% | 2.37% |
| 31 Mar, 18 | 41.17% | 2.36% |
| 31 Dec, 17 | 41.77% | 2.46% |
| 30 Sep, 17 | 41.20% | 2.08% |
| 30 Jun, 17 | 44.56% | 2.69% |
| 31 Mar, 17 | 40.73% | 2.37% |
| 31 Dec, 16 | 41.42% | 2.35% |
| 30 Sep, 16 | 42.01% | 1.98% |
| 30 Jun, 16 | 46.01% | 2.48% |
| 31 Mar, 16 | 43.04% | 1.82% |
| 31 Dec, 15 | 48.61% | 2.04% |
| 30 Sep, 15 | 48.79% | 1.85% |
| 30 Jun, 15 | 51.38% | 1.41% |
| 31 Mar, 15 | 60.40% | 2.93% |
| 31 Dec, 14 | 45.41% | 1.98% |
| 30 Sep, 14 | 47.84% | 1.87% |
| 30 Jun, 14 | 50.62% | 1.61% |
| 31 Mar, 14 | 56.00% | 1.38% |
| 31 Dec, 13 | 63.63% | 2.67% |
| 30 Sep, 13 | 48.78% | 2.14% |
| 30 Jun, 13 | 47.72% | 4.13% |
| 31 Mar, 13 | 34.01% | 2.35% |
| 31 Dec, 12 | 38.06% | 2.97% |
| 30 Sep, 12 | 35.79% | 2.85% |
| 30 Jun, 12 | 35.42% | 7.16% |
| 31 Mar, 12 | 22.23% | 2.17% |
| 31 Dec, 11 | 32.03% | 13.08% |
| 30 Sep, 11 | 15.65% | 3.31% |
| 30 Jun, 11 | 21.75% | 21.70% |
| 31 Mar, 11 | 10.01% | 4.30% |
| 31 Dec, 10 | 15.26% | 5.39% |
| 30 Sep, 10 | 16.83% | 4.43% |
| 30 Jun, 10 | 19.49% | 11.75% |
| 31 Mar, 10 | 12.88% | 1.41% |
| 31 Dec, 09 | 30.22% | 338.74% |
| 30 Sep, 09 | 2.99% | 14.22% |
| 30 Jun, 09 | 4.58% | 35.62% |
| 31 Mar, 09 | 3.59% | 24.36% |
| 31 Dec, 08 | 3.84% | 88.23% |
| 30 Sep, 08 | 2.09% | 2.49% |
| 30 Jun, 08 | 9.16% | 37.80% |
| 31 Mar, 08 | 4.92% | 3.45% |
| 31 Dec, 07 | 11.95% | 11.39% |
| 30 Sep, 07 | 10.24% | 35.12% |
| 30 Jun, 07 | 5.40% | 11.03% |
| 31 Mar, 07 | 7.00% | 5.19% |
| 31 Dec, 06 | 11.61% | - |
| 30 Jun, 06 | 5.22% | - |
As of 31 Mar 24, Alaunos Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | - | -100.00% |
| 31 Dec, 23 | 17 | - |
| 30 Sep, 23 | 17 | -37.04% |
| 30 Jun, 23 | 27 | -6.90% |
| 31 Mar, 23 | 29 | -44.23% |
| 31 Dec, 22 | 52 | -10.34% |
| 30 Sep, 22 | 58 | 38.10% |
| 30 Jun, 22 | 42 | -12.50% |
| 31 Mar, 22 | 48 | -35.14% |
| 31 Dec, 21 | 74 | -16.85% |
| 30 Sep, 21 | 89 | 32.84% |
| 30 Jun, 21 | 67 | -11.84% |
| 31 Mar, 21 | 76 | 15.15% |
| 31 Dec, 20 | 66 | - |
| 30 Sep, 20 | 66 | -13.16% |
| 30 Jun, 20 | 76 | -2.56% |
| 31 Mar, 20 | 78 | 4.00% |
| 31 Dec, 19 | 75 | 2.74% |
| 30 Sep, 19 | 73 | -9.88% |
| 30 Jun, 19 | 81 | 65.31% |
| 31 Mar, 19 | 49 | -19.67% |
| 31 Dec, 18 | 61 | 27.08% |
| 30 Sep, 18 | 48 | -5.88% |
| 30 Jun, 18 | 51 | -3.77% |
| 31 Mar, 18 | 53 | -7.02% |
| 31 Dec, 17 | 57 | 18.75% |
| 30 Sep, 17 | 48 | -18.64% |
| 30 Jun, 17 | 59 | 15.69% |
| 31 Mar, 17 | 51 | -21.54% |
| 31 Dec, 16 | 65 | 8.33% |
| 30 Sep, 16 | 60 | -31.03% |
| 30 Jun, 16 | 87 | 22.54% |
| 31 Mar, 16 | 71 | -21.98% |
| 31 Dec, 15 | 91 | 28.17% |
| 30 Sep, 15 | 71 | -43.65% |
| 30 Jun, 15 | 126 | 17.76% |
| 31 Mar, 15 | 107 | 137.78% |
| 31 Dec, 14 | 45 | 15.38% |
| 30 Sep, 14 | 39 | -13.33% |
| 30 Jun, 14 | 45 | -13.46% |
| 31 Mar, 14 | 52 | -5.45% |
| 31 Dec, 13 | 55 | 61.76% |
| 30 Sep, 13 | 34 | -37.04% |
| 30 Jun, 13 | 54 | 125.00% |
| 31 Mar, 13 | 24 | 14.29% |
| 31 Dec, 12 | 21 | -12.50% |
| 30 Sep, 12 | 24 | 33.33% |
| 30 Jun, 12 | 18 | - |
| 31 Mar, 12 | 18 | - |
| 31 Dec, 11 | 18 | 63.64% |
| 30 Sep, 11 | 11 | -38.89% |
| 30 Jun, 11 | 18 | -5.26% |
| 31 Mar, 11 | 19 | 35.71% |
| 31 Dec, 10 | 14 | 40.00% |
| 30 Sep, 10 | 10 | -50.00% |
| 30 Jun, 10 | 20 | 566.67% |
| 31 Mar, 10 | 3 | -57.14% |
| 31 Dec, 09 | 7 | 600.00% |
| 30 Sep, 09 | 1 | -50.00% |
| 30 Jun, 09 | 2 | - |
| 31 Mar, 09 | 2 | -33.33% |
| 31 Dec, 08 | 3 | -25.00% |
| 30 Sep, 08 | 4 | 33.33% |
| 30 Jun, 08 | 3 | 200.00% |
| 31 Mar, 08 | 1 | -75.00% |
| 31 Dec, 07 | 4 | 300.00% |
| 30 Sep, 07 | 1 | -50.00% |
| 30 Jun, 07 | 2 | -33.33% |
| 31 Mar, 07 | 3 | -25.00% |
| 31 Dec, 06 | 4 | - |
| 30 Jun, 06 | 1 | - |
- institutional shareholders have increased their position in TCRT stock as of 31 Mar 24 compared to 17 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | - | -100.00% |
| 31 Dec, 23 | 27 | -3.57% |
| 30 Sep, 23 | 28 | 16.67% |
| 30 Jun, 23 | 24 | -22.58% |
| 31 Mar, 23 | 31 | 6.90% |
| 31 Dec, 22 | 29 | -3.33% |
| 30 Sep, 22 | 30 | -26.83% |
| 30 Jun, 22 | 41 | - |
| 31 Mar, 22 | 41 | -26.79% |
| 31 Dec, 21 | 56 | 64.71% |
| 30 Sep, 21 | 34 | -24.44% |
| 30 Jun, 21 | 45 | 18.42% |
| 31 Mar, 21 | 38 | -26.92% |
| 31 Dec, 20 | 52 | 10.64% |
| 30 Sep, 20 | 47 | 42.42% |
| 30 Jun, 20 | 33 | 10.00% |
| 31 Mar, 20 | 30 | -11.76% |
| 31 Dec, 19 | 34 | 9.68% |
| 30 Sep, 19 | 31 | 24.00% |
| 30 Jun, 19 | 25 | -10.71% |
| 31 Mar, 19 | 28 | -22.22% |
| 31 Dec, 18 | 36 | - |
| 30 Sep, 18 | 36 | -2.70% |
| 30 Jun, 18 | 37 | 8.82% |
| 31 Mar, 18 | 34 | 9.68% |
| 31 Dec, 17 | 31 | -16.22% |
| 30 Sep, 17 | 37 | 5.71% |
| 30 Jun, 17 | 35 | -7.89% |
| 31 Mar, 17 | 38 | 2.70% |
| 31 Dec, 16 | 37 | - |
| 30 Sep, 16 | 37 | 8.82% |
| 30 Jun, 16 | 34 | -26.09% |
| 31 Mar, 16 | 46 | 24.32% |
| 31 Dec, 15 | 37 | -30.19% |
| 30 Sep, 15 | 53 | 89.29% |
| 30 Jun, 15 | 28 | 64.71% |
| 31 Mar, 15 | 17 | -22.73% |
| 31 Dec, 14 | 22 | -29.03% |
| 30 Sep, 14 | 31 | 14.81% |
| 30 Jun, 14 | 27 | 12.50% |
| 31 Mar, 14 | 24 | 200.00% |
| 31 Dec, 13 | 8 | -66.67% |
| 30 Sep, 13 | 24 | 300.00% |
| 30 Jun, 13 | 6 | -40.00% |
| 31 Mar, 13 | 10 | 66.67% |
| 31 Dec, 12 | 6 | 200.00% |
| 30 Sep, 12 | 2 | -66.67% |
| 30 Jun, 12 | 6 | 50.00% |
| 31 Mar, 12 | 4 | 33.33% |
| 31 Dec, 11 | 3 | -40.00% |
| 30 Sep, 11 | 5 | -28.57% |
| 30 Jun, 11 | 7 | 75.00% |
| 31 Mar, 11 | 4 | -20.00% |
| 31 Dec, 10 | 5 | 25.00% |
| 30 Sep, 10 | 4 | 300.00% |
| 30 Jun, 10 | 1 | -50.00% |
| 31 Mar, 10 | 2 | - |
| 31 Dec, 09 | - | -100.00% |
| 30 Sep, 09 | 1 | -50.00% |
| 30 Jun, 09 | 2 | - |
| 31 Mar, 09 | 2 | -33.33% |
| 31 Dec, 08 | 3 | 200.00% |
| 30 Sep, 08 | 1 | - |
| 30 Jun, 08 | 1 | - |
| 31 Mar, 08 | 1 | - |
| 31 Dec, 07 | 1 | -50.00% |
| 30 Sep, 07 | 2 | -33.33% |
| 30 Jun, 07 | 3 | - |
| 31 Mar, 07 | 3 | - |
| 31 Dec, 06 | - | - |
| 30 Jun, 06 | - | - |
- institutional shareholders have reduced their position in TCRT stock as of 31 Mar 24 compared to 27 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 1 | -98.80% | 40 | -100.00% | 0.00% | - | - | -100.00% | - | -100.00% |
| 31 Dec, 23 | 83 | -9.78% | 41,174,501 | -26.49% | 17.15% | 3.14% | 17 | - | 27 | -3.57% |
| 30 Sep, 23 | 92 | -14.02% | 56,012,255 | -16.44% | 23.36% | 2.99% | 17 | -37.04% | 28 | 16.67% |
| 30 Jun, 23 | 107 | -7.76% | 67,033,956 | -5.32% | 27.97% | 3.21% | 27 | -6.90% | 24 | -22.58% |
| 31 Mar, 23 | 116 | -10.77% | 70,801,563 | -9.01% | 29.54% | 2.30% | 29 | -44.23% | 31 | 6.90% |
| 31 Dec, 22 | 130 | -1.52% | 77,812,599 | 4.33% | 35.84% | 2.98% | 52 | -10.34% | 29 | -3.33% |
| 30 Sep, 22 | 132 | 4.76% | 74,585,144 | 1.99% | 34.67% | 3.00% | 58 | 38.10% | 30 | -26.83% |
| 30 Jun, 22 | 126 | -14.86% | 73,126,482 | -27.10% | 34.01% | 1.56% | 42 | -12.50% | 41 | - |
| 31 Mar, 22 | 148 | -13.45% | 100,314,073 | -29.80% | 46.67% | 1.05% | 48 | -35.14% | 41 | -26.79% |
| 31 Dec, 21 | 171 | -0.58% | 142,905,382 | 34.36% | 66.57% | 2.71% | 74 | -16.85% | 56 | 64.71% |
| 30 Sep, 21 | 172 | 5.52% | 106,357,480 | -5.50% | 49.57% | 1.80% | 89 | 32.84% | 34 | -24.44% |
| 30 Jun, 21 | 163 | 2.52% | 112,545,246 | -4.12% | 52.49% | 1.74% | 67 | -11.84% | 45 | 18.42% |
| 31 Mar, 21 | 159 | -3.05% | 117,383,729 | 5.22% | 54.86% | 1.94% | 76 | 15.15% | 38 | -26.92% |
| 31 Dec, 20 | 164 | 1.23% | 111,554,996 | 3.80% | 53.21% | 2.09% | 66 | - | 52 | 10.64% |
| 30 Sep, 20 | 162 | 3.85% | 107,467,415 | 4.57% | 50.49% | 2.16% | 66 | -13.16% | 47 | 42.42% |
| 30 Jun, 20 | 156 | 1.96% | 102,769,692 | 3.99% | 48.30% | 1.97% | 76 | -2.56% | 33 | 10.00% |
| 31 Mar, 20 | 153 | -4.38% | 98,826,017 | 15.22% | 49.46% | 1.90% | 78 | 4.00% | 30 | -11.76% |
| 31 Dec, 19 | 160 | 3.90% | 85,770,320 | 3.76% | 51.07% | 2.18% | 75 | 2.74% | 34 | 9.68% |
| 30 Sep, 19 | 154 | 2.67% | 82,666,131 | 17.80% | 48.45% | 2.54% | 73 | -9.88% | 31 | 24.00% |
| 30 Jun, 19 | 150 | 12.78% | 70,175,585 | 12.38% | 43.64% | 2.89% | 81 | 65.31% | 25 | -10.71% |
| 31 Mar, 19 | 133 | -6.99% | 62,447,382 | 1.34% | 38.87% | 2.11% | 49 | -19.67% | 28 | -22.22% |
| 31 Dec, 18 | 143 | - | 61,621,466 | 7.21% | 42.94% | 2.59% | 61 | 27.08% | 36 | - |
| 30 Sep, 18 | 143 | -2.05% | 57,478,663 | 1.66% | 40.71% | 2.53% | 48 | -5.88% | 36 | -2.70% |
| 30 Jun, 18 | 146 | 0.69% | 56,537,882 | -2.50% | 40.09% | 2.37% | 51 | -3.77% | 37 | 8.82% |
| 31 Mar, 18 | 145 | 2.84% | 57,990,213 | 1.38% | 41.17% | 2.36% | 53 | -7.02% | 34 | 9.68% |
| 31 Dec, 17 | 141 | 0.71% | 57,198,716 | -1.28% | 41.77% | 2.46% | 57 | 18.75% | 31 | -16.22% |
| 30 Sep, 17 | 140 | 2.19% | 57,938,065 | -4.13% | 41.20% | 2.08% | 48 | -18.64% | 37 | 5.71% |
| 30 Jun, 17 | 137 | -4.20% | 60,433,369 | 13.52% | 44.56% | 2.69% | 59 | 15.69% | 35 | -7.89% |
| 31 Mar, 17 | 143 | -12.27% | 53,235,763 | -1.53% | 40.73% | 2.37% | 51 | -21.54% | 38 | 2.70% |
| 31 Dec, 16 | 163 | 1.24% | 54,062,432 | -1.38% | 41.42% | 2.35% | 65 | 8.33% | 37 | - |
| 30 Sep, 16 | 161 | -9.55% | 54,818,463 | -8.61% | 42.01% | 1.98% | 60 | -31.03% | 37 | 8.82% |
| 30 Jun, 16 | 178 | 8.54% | 59,985,931 | 7.07% | 46.01% | 2.48% | 87 | 22.54% | 34 | -26.09% |
| 31 Mar, 16 | 164 | -6.82% | 56,024,521 | -8.11% | 43.04% | 1.82% | 71 | -21.98% | 46 | 24.32% |
| 31 Dec, 15 | 176 | 11.39% | 60,969,223 | -3.68% | 48.61% | 2.04% | 91 | 28.17% | 37 | -30.19% |
| 30 Sep, 15 | 158 | -14.13% | 63,300,262 | -4.06% | 48.79% | 1.85% | 71 | -43.65% | 53 | 89.29% |
| 30 Jun, 15 | 184 | 22.67% | 65,976,582 | -3.69% | 51.38% | 1.41% | 126 | 17.76% | 28 | 64.71% |
| 31 Mar, 15 | 150 | 57.89% | 68,501,010 | 49.17% | 60.40% | 2.93% | 107 | 137.78% | 17 | -22.73% |
| 31 Dec, 14 | 95 | -8.65% | 45,922,525 | -4.43% | 45.41% | 1.98% | 45 | 15.38% | 22 | -29.03% |
| 30 Sep, 14 | 104 | 1.96% | 48,049,607 | -5.47% | 47.84% | 1.87% | 39 | -13.33% | 31 | 14.81% |
| 30 Jun, 14 | 102 | -2.86% | 50,831,715 | -9.44% | 50.62% | 1.61% | 45 | -13.46% | 27 | 12.50% |
| 31 Mar, 14 | 105 | 22.09% | 56,130,056 | 2.64% | 56.00% | 1.38% | 52 | -5.45% | 24 | 200.00% |
| 31 Dec, 13 | 86 | 1.18% | 54,688,537 | 34.81% | 63.63% | 2.67% | 55 | 61.76% | 8 | -66.67% |
| 30 Sep, 13 | 85 | 8.97% | 40,567,489 | 2.33% | 48.78% | 2.14% | 34 | -37.04% | 24 | 300.00% |
| 30 Jun, 13 | 78 | 85.71% | 39,643,429 | 40.61% | 47.72% | 4.13% | 54 | 125.00% | 6 | -40.00% |
| 31 Mar, 13 | 42 | 23.53% | 28,193,221 | -5.69% | 34.01% | 2.35% | 24 | 14.29% | 10 | 66.67% |
| 31 Dec, 12 | 34 | 3.03% | 29,893,241 | 6.16% | 38.06% | 2.97% | 21 | -12.50% | 6 | 200.00% |
| 30 Sep, 12 | 33 | 6.45% | 28,158,200 | 1.26% | 35.79% | 2.85% | 24 | 33.33% | 2 | -66.67% |
| 30 Jun, 12 | 31 | 14.81% | 27,808,953 | 65.40% | 35.42% | 7.16% | 18 | - | 6 | 50.00% |
| 31 Mar, 12 | 27 | 12.50% | 16,813,551 | -20.47% | 22.23% | 2.17% | 18 | - | 4 | 33.33% |
| 31 Dec, 11 | 24 | 26.32% | 21,139,899 | 98.37% | 32.03% | 13.08% | 18 | 63.64% | 3 | -40.00% |
| 30 Sep, 11 | 19 | -34.48% | 10,656,705 | -27.13% | 15.65% | 3.31% | 11 | -38.89% | 5 | -28.57% |
| 30 Jun, 11 | 29 | 7.41% | 14,624,783 | 141.79% | 21.75% | 21.70% | 18 | -5.26% | 7 | 75.00% |
| 31 Mar, 11 | 27 | 17.39% | 6,048,479 | -13.84% | 10.01% | 4.30% | 19 | 35.71% | 4 | -20.00% |
| 31 Dec, 10 | 23 | 15.00% | 7,019,856 | -12.06% | 15.26% | 5.39% | 14 | 40.00% | 5 | 25.00% |
| 30 Sep, 10 | 20 | -9.09% | 7,982,382 | -3.34% | 16.83% | 4.43% | 10 | -50.00% | 4 | 300.00% |
| 30 Jun, 10 | 22 | 144.44% | 8,258,136 | 59.67% | 19.49% | 11.75% | 20 | 566.67% | 1 | -50.00% |
| 31 Mar, 10 | 9 | 12.50% | 5,171,873 | -25.94% | 12.88% | 1.41% | 3 | -57.14% | 2 | - |
| 31 Dec, 09 | 8 | 100.00% | 6,982,909 | 974.46% | 30.22% | 338.74% | 7 | 600.00% | - | -100.00% |
| 30 Sep, 09 | 4 | -33.33% | 649,898 | -33.45% | 2.99% | 14.22% | 1 | -50.00% | 1 | -50.00% |
| 30 Jun, 09 | 6 | 20.00% | 976,532 | 27.78% | 4.58% | 35.62% | 2 | - | 2 | - |
| 31 Mar, 09 | 5 | -16.67% | 764,231 | -6.20% | 3.59% | 24.36% | 2 | -33.33% | 2 | -33.33% |
| 31 Dec, 08 | 6 | - | 814,760 | 84.03% | 3.84% | 88.23% | 3 | -25.00% | 3 | 200.00% |
| 30 Sep, 08 | 6 | 20.00% | 442,729 | -77.23% | 2.09% | 2.49% | 4 | 33.33% | 1 | - |
| 30 Jun, 08 | 5 | 25.00% | 1,944,624 | 86.09% | 9.16% | 37.80% | 3 | 200.00% | 1 | - |
| 31 Mar, 08 | 4 | -42.86% | 1,045,001 | -53.56% | 4.92% | 3.45% | 1 | -75.00% | 1 | - |
| 31 Dec, 07 | 7 | 40.00% | 2,250,304 | 3.64% | 11.95% | 11.39% | 4 | 300.00% | 1 | -50.00% |
| 30 Sep, 07 | 5 | -16.67% | 2,171,320 | 89.79% | 10.24% | 35.12% | 1 | -50.00% | 2 | -33.33% |
| 30 Jun, 07 | 6 | - | 1,144,038 | -7.31% | 5.40% | 11.03% | 2 | -33.33% | 3 | - |
| 31 Mar, 07 | 6 | 50.00% | 1,234,308 | -39.72% | 7.00% | 5.19% | 3 | -25.00% | 3 | - |
| 31 Dec, 06 | 4 | - | 2,047,627 | - | 11.61% | - | 4 | - | - | - |
| 30 Jun, 06 | 1 | - | 647,948 | - | 5.22% | - | 1 | - | - | - |
Alaunos Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Alaunos Therapeutics's stock was made by Boyle Kevin S. Sr. on Sep 05 2023, selling 68,014 shares at $0.14 per share (valued at $9.54K).
Alaunos Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | 5 | - | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | 2 | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 7 | - | - |
| Q4 2022 | 2 | - | - |
| Q3 2022 | 5 | 2 | 250.00% |
| Q2 2022 | 10 | - | - |
| Q1 2022 | 3 | 6 | 50.00% |
| Q4 2021 | 3 | 2 | 150.00% |
| Q3 2021 | 8 | - | - |
| Q2 2021 | 1 | - | - |
| Q1 2021 | 26 | 9 | 288.89% |
| Q4 2020 | 1 | 2 | 50.00% |
| Q3 2020 | 1 | - | - |
| Q1 2020 | 13 | 5 | 260.00% |
| Q4 2019 | 11 | 6 | 183.33% |
| Q3 2019 | 1 | - | - |
2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Alaunos Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 2 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 2 | 1 | 200.00% |
| Q3 2021 | 6 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 5 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q1 2020 | - | 5 | - |
| Q4 2019 | - | 2 | - |
| Q3 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Alaunos Therapeutics's stocks.
Alaunos Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| CKPT | Checkpoint Therapeutics, Inc. |
| CUE | Cue Biopharma, Inc. |
| ACHL | Achilles Therapeutics plc |
| LRMR | Larimar Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ADAP | Adaptimmune Therapeutics plc |
| BDTX | Black Diamond Therapeutics, Inc. |
| RIGL | Rigel Pharmaceuticals, Inc. |
| FENC | Fennec Pharmaceuticals Inc. |
| LIAN | LianBio |
| MDNA | Medicenna Therapeutics Corp. |
| MRSN | Mersana Therapeutics, Inc. |
| INKT | MiNK Therapeutics, Inc. |
| PIRS | Pieris Pharmaceuticals, Inc. |
| VRCA | Verrica Pharmaceuticals Inc. |
| FIXX | Q32 Bio Inc. |
TCRT Ownership FAQ
Who Owns Alaunos Therapeutics?
Alaunos Therapeutics is owned by institutional shareholders (0.00%), insiders (14.30%), and public (85.70%). The largest institutional shareholder of Alaunos Therapeutics is EVERSOURCE WEALTH ADVISORS, LLC (0% of total shares) and the top mutual fund owner is Federated Hermes MDT Series (0.09% of total shares).
Who are the major institutional shareholders of Alaunos Therapeutics?
Alaunos Therapeutics's major institutional shareholders are EVERSOURCE WEALTH ADVISORS, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Alaunos Therapeutics shareholders are there?
As of Mar 2024, there are 1 institutional shareholders of Alaunos Therapeutics.
What percentage of Alaunos Therapeutics is owned by EVERSOURCE WEALTH ADVISORS, LLC?
EVERSOURCE WEALTH ADVISORS, LLC owns 0 shares of Alaunos Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).